Prev:Combating atherosclerosis with chirality/phase dual‐engineered nanozyme featuring microenvironment‐programmed senolytic and senomorphic actions.(KTB1030-27)
Next:Combating atherosclerosis with chirality/phase dual‐engineered nanozyme featuring microenvironment‐programmed senolytic and senomorphic actions.(KTB1310-27)